MTOR and hyperlipidemia: Other side effects seen with mTOR inhibitors include metabolic derangements such as hyperglycemia and hyperlipidemia, which mandate close monitoring of blood glucose and lipid profile routinely while on everolimus and utilization of anti-hyperglycemic agents and statins for the biochemical control [162].